Mackay Shields LLC Atara Biotherapeutics, Inc. Transaction History

Mackay Shields LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$12.89 - $16.58 $586,391 - $754,257	-45,492 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$14.0 - $20.72 $336,546 - $498,088	-24,039 Reduced 34.57%	45,492 $653,000
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $178,647 - $369,843	-14,100 Reduced 16.86%	69,531 $1.37 Million
Q3 2020 Nov 04, 2020	SELL	$11.92 - $15.87 $153,768 - $204,723	-12,900 Reduced 13.36%	83,631 $1.08 Million
Q2 2020 Jul 31, 2020	BUY	$7.53 - $14.93 $96,384 - $191,104	12,800 Added 15.29%	96,531 $1.41 Million
Q1 2020 May 08, 2020	BUY	$5.69 - $17.78 $69,987 - $218,694	12,300 Added 17.22%	83,731 $713,000
Q4 2019 Feb 11, 2020	BUY	$10.89 - $16.79 $44,649 - $68,839	4,100 Added 6.09%	71,431 $1.18 Million
Q3 2019 Nov 01, 2019	BUY	$12.03 - $19.94 $169,623 - $281,154	14,100 Added 26.49%	67,331 $951,000
Q2 2019 Aug 13, 2019	BUY	$19.05 - $41.04 $709,402 - $1.53 Million	37,239 Added 232.86%	53,231 $1.07 Million
Q1 2019 May 13, 2019	BUY	$28.4 - $41.74 $14,200 - $20,870	500 Added 3.23%	15,992 $636,000
Q4 2018 Feb 14, 2019	BUY	$30.9 - $42.97 $478,702 - $665,691	15,492 New	15,492 $538,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $469,669 - $582,900	-13,400 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$35.15 - $51.45 $471,010 - $689,430	13,400 New	13,400 $493,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.